)
Visual
test
Sai Life Sciences
Sai Life Sciences (SAILIFE) investor relations material
Sai Life Sciences Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary6 Feb, 2026
Executive summary
Achieved strong revenue and profit growth in Q3 FY26, outpacing the broader CRDMO industry, with performance ahead of plan and broad-based demand across CDMO and CRO segments.
Strategic focus on expanding large pharma partnerships, supply chain resilience, and next-gen technology adoption, including AI and advanced platforms.
Ongoing transformation and productivity initiatives, with external consulting for AI enablement and automation to drive efficiency.
Board approved unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, with statutory auditor review and unmodified conclusion.
Expanded organizational depth by adding experienced scientific and leadership talent, aligning with capacity expansion and long-term strategy.
Financial highlights
Q3 FY26 consolidated revenue at INR 556 crore (Rs. 5,564.64 million), up 27% year-over-year; CDMO contributed 65%, CRO 35%.
Q3 EBITDA at INR 191 crore, up 54% year-over-year, with a 34% margin; PAT at INR 100 crore, up 86%.
Nine-month FY26 consolidated revenue at INR 1,590 crore (Rs. 15,903.53 million), up 43% year-over-year; EBITDA at INR 472 crore, up 79%, with margin expansion to 30%.
PAT for nine months at INR 245 crore, up 199% year-over-year.
Standalone and consolidated net profit for the quarter: Rs. 976.30 million and Rs. 1,003.75 million, respectively.
Outlook and guidance
Margin guidance of 28%-30% to be sustained, balancing growth and operational efficiency.
Revenue growth expected to remain broad-based, with no pull-forward from future years; guidance remains at 15%-20% CAGR over 3–5 years.
Growth momentum expected to continue, supported by a solid order pipeline and resilient operating foundation.
Ongoing investments in capacity and technology to support future demand and maintain growth momentum.
No explicit forward-looking guidance provided in statutory filings, but recent IPO and ESOP grants indicate ongoing growth and investment in talent.
Future impact of Labour Codes on operations?
Details on general corporate purposes IPO funds?
What is the potential dilution from ESOP grants?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebMGY
Record production, strong free cash flow, and disciplined capital returns defined 2025. - 6 FebQNST
Record Q2 revenue, $50.2M net income, HomeBuddy acquisition, and AI drive growth. - 6 FebOPGN
Shareholders will vote on seven key proposals, including a new equity plan and company name change. - 6 FebCDP
2025 FFO/share up 5.8% with strong leasing; 2026 outlook positive amid record defense spending. - 6 FebVTR
2025 saw double-digit SHOP NOI and FFO growth, a raised dividend, and $2.5B in investments. - 6 FebREG
2025 delivered record NOI and FFO growth, with 2026 guidance projecting further gains. - 6 FebMNTS
All stock issuance proposals passed except the share increase, which was not approved. - 6 FebCPT
2025 beat guidance; 2026 sees lower FFO, Sun Belt focus, and major asset sales with share repurchases. - 6 FebKOG
Record growth, robust backlog, and a NOK 5.70 dividend proposal drive future expansion. - 6 FebTSBK
Net income rose 19.8% to $8.22M, with higher margins, strong capital, and a dividend increase.
Next Sai Life Sciences earnings date
Q4 25/2615 May, 2026
Sai Life Sciences
Next Sai Life Sciences earnings date
Q4 25/2615 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage